Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,031,054
- Total 13F value
- $12,488,021
- Share change
- -84,102
- Put/Call ratio
- 67%
- SEC-reported price per share
- $4.12
- Number of holders
- 40
- Value change
- -$296,992
- Number of buys
- 12
- Number of sells
- 9
- Shares outstanding
- 11,676,558
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
40
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Ownership snapshot
Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rubric Capital Management LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
Rubric Capital Management LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rubric Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Rubric Capital Management LP
10%
Clearline Capital LP
3.6%
VANGUARD GROUP INC
3.3%
Tejara Capital Ltd
3%
MORGAN STANLEY
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
Company
|
10%
|
$4,470,716
1,192,191 shares
|
— | 31 Mar 2023 |
| Clearline Capital LP |
13F
Company
|
3.6%
|
$1,572,844
419,425 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$1,444,680
385,248 shares
|
— | 31 Mar 2023 |
| Tejara Capital Ltd |
13F
Company
|
3%
|
$1,333,796
355,679 shares
|
— | 31 Mar 2023 |
| MORGAN STANLEY |
13F
Company
|
1.1%
|
$501,480
133,728 shares
|
— | 31 Mar 2023 |
| Sixth Street Partners Management Company, L.P. |
13F
Company
|
1.1%
|
$467,471
124,659 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
3,031,054
Rows available
40
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
38
Q2 2023 holders
40
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend